Apollo Endosurgery, Inc.
APEN
APEN was delisted on the 3rd of April, 2023.
89 hedge funds and large institutions have $442M invested in Apollo Endosurgery, Inc. in 2023 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 33 increasing their positions, 20 reducing their positions, and 21 closing their positions.
73,045% more call options, than puts
Call options by funds: $21.2M | Put options by funds: $29K
65% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 20
38% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 21
20% more capital invested
Capital invested by funds: $368M → $442M (+$74M)
13% more funds holding in top 10
Funds holding in top 10: 8 → 9 (+1)
10% more funds holding
Funds holding: 81 → 89 (+8)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NAM
Nexpoint Asset Management
Dallas,
Texas
|
+$35.7M |
| 2 |
SSA
Schonfeld Strategic Advisors
New York
|
+$17M |
| 3 |
GLAM
Gardner Lewis Asset Management
Chadds Ford,
Pennsylvania
|
+$14.2M |
| 4 |
E
Ergoteles
New York
|
+$14M |
| 5 |
Millennium Management
New York
|
+$14M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$33.2M |
| 2 |
DM
Deerfield Management
New York
|
-$17.4M |
| 3 |
ACM
Archon Capital Management
Seattle,
Washington
|
-$16.4M |
| 4 |
GS
Gagnon Securities
New York
|
-$16.2M |
| 5 |
GA
Gagnon Advisors
New York
|
-$13.3M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
HF
101
HRT Financial
New York
| – | -$803K | -80,598 | Closed |
|
|
WVP
102
Worth Venture Partners
Fort Lee,
New Jersey
| – | -$775K | -77,696 | Closed |
|
103
Dimensional Fund Advisors
Austin,
Texas
| – | -$611 | -61,247 | Closed |
|
|
TI
104
Trexquant Investment
Stamford,
Connecticut
| – | -$488K | -48,973 | Closed |
|
|
QT
105
Quantbot Technologies
New York
| – | -$241K | -24,125 | Closed |
|
|
CSS
106
Cubist Systematic Strategies
Stamford,
Connecticut
| – | -$196K | -19,623 | Closed |
|
|
LIP
107
Lighthouse Investment Partners
Palm Beach Gardens,
Florida
| – | -$160K | -16,065 | Closed |
|
108
Squarepoint
New York
| – | -$126K | -12,658 | Closed |
|
|
MFS
109
Mirabella Financial Services
London,
United Kingdom
| – | -$121K | -12,120 | Closed |
|
110
Lazard Asset Management
New York
| – | -$56K | -5,701 | Closed |
|
111
Group One Trading
Chicago,
Illinois
| – | -$3.57K | -360 | Closed |
|
APEN Hedge Fund Activity: Q1 2023 in Review
89 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Apollo Endosurgery, Inc. (APEN) for Q1 2023, worth a combined $442M — up 20% from $368M a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new APEN positions and 21 closed out — a net gain of 8 holders — while 33 added to existing stakes and 20 trimmed.
The largest buyer was Nexpoint Asset Management, adding an estimated $35.7M. The largest seller was Stonepine Capital Management, cutting an estimated $33.2M.
- 89 institutional investors held Apollo Endosurgery, Inc. (APEN) as of Q1 2023, up from 81 in Q4 2022.
- Funds reported $442M of Apollo Endosurgery, Inc. stock for Q1 2023, up 20% quarter-over-quarter.
- 29 funds opened new Apollo Endosurgery, Inc. positions in Q1 2023 and 21 closed out, a net change of +8 holders.
- The largest Apollo Endosurgery, Inc. buyer in Q1 2023 was Nexpoint Asset Management, an estimated $35.7M added.
- The largest Apollo Endosurgery, Inc. seller in Q1 2023 was Stonepine Capital Management, an estimated $33.2M sold.
Based on aggregated 13F filings for Q1 2023.